05/08/2024
6:54 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
6:49 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/10/2024
3:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B3 | |
04/10/2024
6:46 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form EFFECT | |
04/05/2024
6:39 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-3/A | |
04/01/2024
4:27 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/26/2024
7:28 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
6:34 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
7:24 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
8:39 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/02/2024
8:22 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:13 PM | Guenther Sven (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:14 PM | Mickle Christal M M (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:17 PM | Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:08 PM | Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:10 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:11 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:13 AM | Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SC 13G | |
01/23/2024
6:37 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:03 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
6:48 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
6:40 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B5 | |
11/20/2023
6:36 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:25 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
3:42 PM | ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 425 | |
10/30/2023
7:25 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
3:33 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
11:15 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form EFFECT | |
10/10/2023
7:20 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/10/2023
4:07 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 424B3 | |
10/10/2023
4:12 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:06 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-4/A | |
09/28/2023
8:25 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
09/06/2023
3:39 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
3:40 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2023
4:25 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2023
4:25 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
08/31/2023
7:01 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Crypto 9-5 Escape Plan (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
08/31/2023
7:03 AM | ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 425 | |
08/25/2023
3:19 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:07 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2023
3:34 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
6:48 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:14 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:19 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:35 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
10:34 AM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
4:53 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
6:57 PM | Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/11/2023
7:02 PM | Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
